Gene therapy preparations manufacturing · California

Capsida Biotherapeutics

Newbury Park, CA · ~128 workers · 3 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.2
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Capsida Biotherapeutics runs at 7% of its industry's injury rate - far safer than the typical Gene therapy preparations manufacturing workplace, earning a grade A.

Capsida Biotherapeutics: 0.2 TCR = 7% of Gene therapy preparations manufacturing BLS 3.3 · 3y Form 300A (see methodology below)

Capsida Biotherapeutics safety composite

Capsida Biotherapeutics scores strongest on total case rate (tcr) (safer than 94% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

79/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0.24 per 100 workers

Safer than 94% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−0.7

2022→2024

Capsida Biotherapeutics injury rate improved

Capsida Biotherapeutics's TCR fell 0.7 from 0.7 in 2022 to 0.0 in 2024. Peak filing year was 2022 at 0.7 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).

2022=0.7 · 2023=0.0 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 325414 · Newbury Park, CA AT/BELOW-IND · MID

Grade A · TCR 0.2 · 7% of ind

  • DART 0.0 DART
  • RANK #2/29
  • PHOTO Krystal Biotech, Inc.
  • BOOK 3y book
  • INJ 1 inj
  • SIZE ~128 FTE

Nearest TCR peer: Krystal Biotech, Inc. (0.0 TCR gap)

Read with this employer → · Industry book → · California employers → · Look up another →

Capsida Biotherapeutics in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Capsida Biotherapeutics averages 0.2 TCR (7% of the Gene therapy preparations manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Capsida Biotherapeutics TCR series: 2022=0.7 · 2023=0 · 2024=0 · BLS 3.3

Where Capsida Biotherapeutics falls in its industry

234 Gene therapy preparations manu establishments

Safer than 94% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #2 safest of 29 Gene therapy preparations manu employers in California.

Capsida Biotherapeutics (128 employees, TCR 0.2) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Capsida Biotherapeutics
Capsida Biotherapeutics (128 employees, TCR 0.2) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Capsida Biotherapeutics has fewer employees than the Gene therapy preparations manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 0.0 0.0 0 0 0
2022 0.7 0.0 1 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · CA · Newbury Park

234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 54 employers in Newbury Park, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Krystal Biotech, Inc. 0.2 TCR
NAICS-TCR Patheon Biologics NJ LLC 0.3 TCR
NAICS-TCR Abbvie Biotechnology Ltd 0.2 TCR
NAICS-TCR Shire: Bannockburn 0.2 TCR
STATE-SIZE Dick Peixoto Company 128 FTE
STATE-SIZE BATTH FARMS 128 FTE
STATE-SIZE Main operations location 128 FTE
STATE-SIZE McIntyre Labor Services, LLC. 128 FTE
CITY-NEAR NEWBURY PARK (WESTLAKE) CENTER (CANEW) 317 FTE
CITY-NEAR CANEW - NEWBURY PARK CENTER 316 FTE
CITY-NEAR People Creating Success 289 FTE
CITY-NEAR 151-70150-33207 261 FTE
NAT-TCR PA41010 0.2 TCR
NAT-TCR Paloma Pressure Control 0.2 TCR
NAT-TCR Water Works Industrial Services, LLC 0.2 TCR
NAT-TCR Tecon Services 0.2 TCR
NAT-SIZE CVD Equipment Corporation 128 FTE
NAT-SIZE Giant 166 128 FTE
NAT-SIZE Giant Landover 235 128 FTE
NAT-SIZE Giant 363 128 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.